Neogen (NEOG) Stock: Buy, Sell, or Hold?
NEOG - Neogen Corp
$11.79
0.07 (0.60%)
▲
5d:
-2.8%
30d:
-15.67%
90d:
+22.68%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 06, 2026
0d
Get Alerted When NEOG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NEOG shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: NEOG shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.26
Based on 4.3% avg growth
INTRINSIC VALUE TODAY
$5.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEOG is currently trading at $11.79, which is considered slightly low relative to its 30-day fair value range of $11.75 to $13.25. From a valuation perspective, the stock is trading at a premium (Forward PE: 39.3) compared to its historical average (31.8). At these levels, the market is pricing in 7.3% annual earnings growth.
Technical Outlook: Technically, NEOG is in a strong uptrend. Immediate support is located at $11.13, while resistance sits at $12.45.
Market Sentiment: NEOG scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+18.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEOG is in a strong uptrend. Immediate support is located at $11.13, while resistance sits at $12.45.
Market Sentiment: NEOG scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+18.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$11.75 -
$13.25
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
91.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (85/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($14.00)
- BULLISH: Expecting earnings turnaround to 7.3% growth with 6.5% revenue growth
- BULLISH: Bottoming setup score 85/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$11.75 -
$13.25
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$11.13
Resistance Level
$12.45
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
39.30
Wall Street Target
$14.00
(+18.7%)
Revenue Growth (YoY)
6.5%
Earnings Growth (YoY)
-85.6%
Profit Margin
-6.3%
Valuation Premium vs History
+7.3% premium
PE vs Historical
39.3 vs 31.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.3%
(market-implied from PE analysis)
1-Year Target
$12.65
(+7%)
2-Year Target
$13.57
(+15%)
3-Year Target
$14.57
(+24%)
3-Yr Target (if PE normalizes)
(PE: 39→32)
PE COMPRESSION
$11.79
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 39.3, Growth: 4.6%)
$13.51
(+15%)
Base:
(SPY PE: 19.9, Growth: 4.6%)
$6.83
(-42%)
Bear:
(PE: 16.9, Growth: 4.6%)
$5.80
(-51%)
Share & Embed Analysis
Last updated: October 21, 2026 7:08 PM ET
Data refreshes hourly during market hours. Next update: 8:08 PM
Data refreshes hourly during market hours. Next update: 8:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEOG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 59 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
Advanced NEOG Option Strategies
Professional options setups generated by AI based on today's NEOG price and gamma walls.